As Capitol Hill debates what the future of the U.S. generic drugs industry will look like, another alarm bell has rung at the Food and Drug Administration (FDA). This time, imported semaglutide generics – similar to Ozempic – sold by a company called the Cheap Medicine Shop were issued an FDA Warning Letter for marketing a drug that had not been approved for sale in the U.S.